Literature DB >> 14992881

The efficacy of supplemental magnesium in reducing atrial fibrillation after coronary artery bypass grafting.

Stephen R Hazelrigg1, Theresa M Boley, Ibrahim B Cetindag, Kreigh P Moulton, Gary L Trammell, Joan E Polancic, Tilitha S Shawgo, Jacquelyn A Quin, Stephen Verhulst.   

Abstract

BACKGROUND: Atrial fibrillation after coronary artery bypass is reported from 17% to 53%. Hypomagnesemia after this surgery is considered a contributing factor.
METHODS: Two hundred-two coronary bypass patients were randomized to magnesium (n = 105) or placebo (n = 97). The experimental group received 80-mg magnesium sulfate per kilogram ideal weight in 100 mL dextrose 5% water 30 minutes preoperatively. Postoperatively, patients received 8-mg magnesium sulfate per kilogram ideal weight intravenous per hour more than 48 hours. The control group received dextrose 5% water at these intervals.
RESULTS: After the first bolus serum magnesium was experimental 4.75 mg/dL versus control 1.91 mg/dL, p less than 0.001, and remained different until postoperative day 4 (experimental 2.33 mg/dL vs control 2.26 mg/dL, p = 0.24). Atrial appendage and strap muscle were analyzed after the first bolus and after revascularization. There were no differences between groups in tissue magnesium or calcium. Urinary magnesium was elevated in the experimental (experimental 324.5 mg/24 hours, vs control 45.1 mg/24 hours, p = 0.01). Calcium excretion was higher (experimental 370 mg/24 hours vs control 186 mg/24 hours, p < 0.001) and was associated with lower serum calcium. Serum calcium was higher in the control through the fourth postoperative day. The incidence of atrial fibrillation was experimental 32 of 105 (30.5%) versus control 41 of 97 (42.3%) p = 0.08. Atrial fibrillation was different on the first postoperative day (experimental 3/105, 2.9% vs control 9/97, 9.3%), p = 0.05.
CONCLUSIONS: Overall prophylactic magnesium supplementation does not significantly reduce atrial and ventricular arrhythmias. The only significant benefit of magnesium supplementation was on the first postoperative day.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14992881     DOI: 10.1016/j.athoracsur.2003.08.027

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

1.  A comparative study between amiodarone and magnesium sulfate as antiarrhythmic agents for prophylaxis against atrial fibrillation following lobectomy.

Authors:  Mohamed A Khalil; Ahmed E Al-Agaty; Wael G Ali; Mohsen S Abdel Azeem
Journal:  J Anesth       Date:  2012-09-18       Impact factor: 2.078

2.  Role of Prophylactic Magnesium Supplementation in Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Coronary Artery Bypass Grafting: a Systematic Review and Meta-Analysis of 20 Randomized Controlled Trials.

Authors:  Rahul Chaudhary; Jalaj Garg; Mohit Turagam; Rohit Chaudhary; Rahul Gupta; Talha Nazir; Babak Bozorgnia; Christine Albert; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2019-06-30

Review 3.  Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: a systematic review.

Authors:  Ioanna Koniari; Efstratios Apostolakis; Christina Rogkakou; Nikolaos G Baikoussis; Dimitrios Dougenis
Journal:  J Cardiothorac Surg       Date:  2010-11-30       Impact factor: 1.637

4.  Intravenous magnesium prevents atrial fibrillation after coronary artery bypass grafting: a meta-analysis of 7 double-blind, placebo-controlled, randomized clinical trials.

Authors:  Wan-Jie Gu; Zhen-Jie Wu; Peng-Fei Wang; Lynn Htet Htet Aung; Rui-Xing Yin
Journal:  Trials       Date:  2012-04-20       Impact factor: 2.279

5.  Does prophylactic sotalol and magnesium decrease the incidence of atrial fibrillation following coronary artery bypass surgery: a propensity-matched analysis.

Authors:  V Aerra; M Kuduvalli; A N Moloto; A K Srinivasan; A D Grayson; B M Fabri; A Y Oo
Journal:  J Cardiothorac Surg       Date:  2006-03-03       Impact factor: 1.637

Review 6.  Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients--a clinical framework.

Authors:  Mengalvio E Sleeswijk; Trudeke Van Noord; Jaap E Tulleken; Jack J M Ligtenberg; Armand R J Girbes; Jan G Zijlstra
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 7.  Postoperative Atrial Fibrillation Following Cardiac Surgery: From Pathogenesis to Potential Therapies.

Authors:  Yousef Rezaei; Mohammad Mehdi Peighambari; Shayan Naghshbandi; Niloufar Samiei; Alireza Alizadeh Ghavidel; Mohammad Reza Dehghani; Majid Haghjoo; Saeid Hosseini
Journal:  Am J Cardiovasc Drugs       Date:  2020-02       Impact factor: 3.571

8.  Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study.

Authors:  Abigail May Khan; Steven A Lubitz; Lisa M Sullivan; Jenny X Sun; Daniel Levy; Ramachandran S Vasan; Jared W Magnani; Patrick T Ellinor; Emelia J Benjamin; Thomas J Wang
Journal:  Circulation       Date:  2012-11-21       Impact factor: 29.690

9.  Intraoperative Magnesium Administration Does Not Reduce Postoperative Atrial Fibrillation After Cardiac Surgery.

Authors:  Rebecca Y Klinger; Christopher A Thunberg; William D White; Manuel Fontes; Nathan H Waldron; Jonathan P Piccini; G Chad Hughes; Mihai V Podgoreanu; Mark Stafford-Smith; Mark F Newman; Joseph P Mathew
Journal:  Anesth Analg       Date:  2015-10       Impact factor: 6.627

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.